ClinTec International celebrates further global expansion and long service awards in clinical excellence
Company on track to deliver its 25% revenue growth target for this year.
ClinTec International celebrated its exceptional year of international growth with Glasgow’s Lord Provost, guests, Country Managers and Directors from over 40 countries, at the ClinTec International Global Conference held in Glasgow last week. Attended by ClinTec International staff and The Right Honourable Lord Provost of Glasgow, Sadie Docherty, the 4-day event celebrated Excellence in Clinical Research Long Service Awards.
ClinTec International is a success story for British business and has recently been recognised as the “UK’s Best Full Service Clinical Research Organisation” at the Healthcare & Pharmaceuticals Awards 2015, organised by Global Health & Pharma. This sits alongside the previously received Queens Award for Enterprise and the 2015 Business Woman of the Year at the Glasgow Business Awards. Commenting on ClinTec International’s growth, the Lord Provost said “ClinTec International has had an exceptional year of growth and they are a great asset to the UK business sector. These awards show the diversity and quality of the team, which has grown together to develop the global business ClinTec International is today.”
ClinTec International is dedicated to nurturing its employees giving them the opportunity to express their talents and capabilities. Building strong teams and promoting group work, along with open minded, individual thinking was always one of the priorities for ClinTec International. The company fosters an open communication culture at all levels without any discriminations, giving the opportunity for everyone to express their opinion.
Bobby Bal, Chief Business Officer said, “This has been an amazing year for us as ClinTec International has expanded its operations into over 50 countries. ClinTec International now has new entities in Japan, Canada, South Korea, New Zealand and Hong Kong. This success lies with our people and their amazing dedication. At ClinTec International we are committed to developing our employees and we are convinced that our employees are our greatest asset. ClinTec International employees work in several international project teams and contribute towards delivering excellence to our clients, who include 7 of the top 10 pharmaceutical and leading biotech companies.”
Founded in 1997 by the Entrepreneur Dr Rabinder Buttar, ClinTec International now operates in over 50 countries. This exceptional growth is continuing as the company is on track to deliver its 25% revenue growth target for this year.
Dr Rabinder Buttar said, “Our people are our greatest asset as we continue to deliver quality global clinical solutions in our fast, flexible and focused way. With our clients, we continue to align ourselves with their needs to deliver exceptional outcomes, which is due to the strength of our team as they innovate and build. Our Global Management Conference is a celebration of what we have achieved, our cultural values and a reminder of what has made us successful. Keeping this balanced view will continue to guide us as ClinTec International continues to deliver fantastic results and sustained organic growth.”
A key step in ClinTec International’s recent African expansion has been the opening of the new office in Johannesburg. This strategic development is allowing ClinTec International to offer enhanced personalised service delivery across Africa. Presentation of the Corporate Achievement Award, won by ClinTec International at the recent African Achievement Awards for its efforts in helping to develop business and achieve growth within Africa was performed at the ClinTec International Global Conference. Beltus Etchu, Chair of African Forum Scotland, said, “This is a most exciting and opportune time for dynamic companies to be active in the African continent. ClinTec International has demonstrated both the insight and foresight to prepare themselves to capture this window of opportunity. They have made marvellous strides in pursuing their ethical and totally professional approach to growing their clinical research business in South Africa, Malawi and now into Kenya. We look forward in the coming years, to assisting ClinTec International further grow into Central and Western Sub-Saharan Africa.’’
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance